ArticleDiabetology international2026

Effects of imeglimin on liver enzymes and body composition in patients with MASLD and type 2 diabetes: a pilot study.

Kaede Fujita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.